Skip to content


Featured article: The Japanese Clinical Practice Guideline for acute kidney injury 2016

oddsratioAcute kidney injury (AKI) is a syndrome which has a broad range of etiologic factors depending on different clinical settings. Because AKI has significant impacts on prognosis in any clinical settings, early detection and intervention are necessary to improve the outcomes of AKI patients.

See this article.

Featured article: Low tongue pressure in peritoneal dialysis patients as a risk factor for malnutrition and sarcopenia: a cross-sectional study

lowtongueLow tongue pressure contributes to oral frailty. It is a condition in which the pressure between the tongue, palate, and food decreases due to a decrease in tongue muscle function.

See this article.

Featured article: Is hemodialysis itself a risk factor for dementia? An analysis of nationwide registry data of patients on maintenance hemodialysis in Japan

hemodialysisChronic kidney disease is a major risk factor for dementia, but the influence of hemodialysis itself on the development of dementia remains unclear. We previously reported that non-diabetic patients on maintenance hemodialysis have preserved cognitive function; hemodialysis removes blood amyloid β (Aβ), which is a major cause of Alzheimer’s disease in the brain; and the number of Aβ deposits in the postmortem brains of hemodialysis patients was significantly less compared to that in age-matched controls not undergoing hemodialysis.

See this article.


Most accessed articles RSS

View all articles

Upcoming conferences

The 64th Annual Meeting of the Japanese Society for Dialysis Therapy
27 - 30 June 2019, Pacifico Yokohama

The 65th Annual Meeting of the Japanese Society for Dialysis Therapy
12−14 June 2020, Osaka International Convention Center, RIHGA Royal Hotel Osaka

The 66th Annual Meeting of the Japanese Society for Dialysis Therapy
June 2021, Pacifico Yokohama

The 52nd Annual Meeting of the Japanese Society for Clinical Renal Transplantation 
13-15 February 2019, Knowledge Capital Congress Convention Center

The 9th Asia Pacific Chapter Meeting of International Society for Peritoneal Dialysis (APCM-ISPD)
5-7 September 2019, Nagoya Congress Center

The 25th Annual Meeting of the Japanese Society for Peritoneal Dialysis
23-24 November - 30 November 2019, Hiroshima International Conference Center

The 29th Annual Meeting of the Japan Society for Blood Purification Critical Care
19 - 20 October 2018, WINC Aichi

The 30th Annual Meeting of the Japan Society for Blood Purification Critical Care
26-27 October 2019, Hamamatsu ACT

The 9th Annual Meeting of the Japanese Society of Renal Rehabilitation
9-10 March 2019, B-ConPlaza (Beppu Convention Center)

Submit your manuscript

RRT logo

Please use the online submission system to submit your manuscript. For all enquiries about the journal, please access the site and click Contact Us.

Aims and scope

Renal Replacement Therapy is a peer-reviewed journal facilitating worldwide discussion of research and issues related to the study of renal replacement therapy.

RRT considers articles on all aspects of hemodialysis, peritoneal dialysis, blood purification, renal transplantation and regenerative medicine. In addition, the journal publishes content in wider fields such as chronic kidney disease (CKD), acute kidney injury (AKI), critical care medicine and intensive care, bone and mineral metabolism, anemia and iron metabolism, infection, cardiac disease, cerebral disease, diabetes mellitus, hypertension, nutrition, and related social issues. Contributions are encouraged from a global perspective across many disciplines.

Overcoming Language Barriers

english editingIf your manuscript could benefit from improvements to the English language, you should have your manuscript reviewed by someone who is fluent in English. For a collection of free resources to help with writing in English please visit here. If you would like professional help, we recommend our affiliates Nature Research Editing Service and American Journal Experts for help with English usage. BMC authors receive 10% off their first submission to either service. Please note that use of an editing service is neither a requirement nor a guarantee of publication.

About the Editor

Prof Takashi Shigematsu, Editor-in-Chief

Prof Shigematsu is currently Professor and Director of the Division of Nephrology, Department of Internal Medicine at the Wakayama Medical University School of Medicine, Japan. He is also Director of Blood purification Medicine, and Clinical Engineering at Wakayama Medical University Hospital, as well as a member of the International Society of Nephrology and the American Society of Nephrology.

His research interests focus on bone and mineral metabolism within chronic kidney disease (CKD). In addition, he has been investigating and working in fields of hemodialysis, peritoneal dialysis, blood purification medicine in acute kidney injury, kidney transplantation.


2017 Journal Metrics

  • Speed
    34 days to first decision for reviewed manuscripts only
    33 days to first decision for all manuscripts
    134 days from submission to acceptance
    21 days from acceptance to publication